SEBVI Trademark

Trademark Overview

On Monday, March 31, 2008, a trademark application was filed for SEBVI with the United States Patent and Trademark Office. The USPTO has given the SEBVI trademark a serial number of 79052852. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, March 31, 2018. This trademark is owned by RiboVax Biotechnologies SA. The SEBVI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the field of immunology; scientific design services, namely, designing antibodies and immunoglobulins for others; technological research in the field of immunology; technological design services, namely, designing antibodies and immunoglobulins for others; scientific research in the field of biology, namely, the immortalization and maintenance of cell cultures containing cells secreting antibodies
sebvi

General Information

Serial Number79052852
Word MarkSEBVI
Filing DateMonday, March 31, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, March 31, 2018
Registration Number3627153
Registration DateTuesday, May 26, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2009

Trademark Statements

Goods and ServicesScientific research in the field of immunology; scientific design services, namely, designing antibodies and immunoglobulins for others; technological research in the field of immunology; technological design services, namely, designing antibodies and immunoglobulins for others; scientific research in the field of biology, namely, the immortalization and maintenance of cell cultures containing cells secreting antibodies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 1, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRiboVax Biotechnologies SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameRiboVax Biotechnologies SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameRiboVax Biotechnologies SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Thursday, October 25, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, October 25, 2018DEATH OF INTERNATIONAL REGISTRATION
Thursday, March 15, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 28, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, September 1, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, September 1, 2016INVALIDATION PROCESSED
Thursday, September 1, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 1, 2016CANCELLED SECTION 71
Monday, April 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 3, 2009FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 3, 2009FINAL DISPOSITION PROCESSED
Wednesday, August 26, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 26, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 2009PUBLISHED FOR OPPOSITION
Wednesday, February 18, 2009NOTICE OF PUBLICATION
Monday, February 2, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 2, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 30, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 30, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 5, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 5, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 5, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 5, 2009ASSIGNED TO LIE
Monday, January 5, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 8, 2008REFUSAL PROCESSED BY IB
Thursday, July 10, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 10, 2008REFUSAL PROCESSED BY MPU
Thursday, July 10, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 9, 2008NON-FINAL ACTION WRITTEN
Wednesday, July 9, 2008ASSIGNED TO EXAMINER
Tuesday, July 1, 2008CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Thursday, June 26, 2008CORRECTION TRANSACTION RECEIVED FROM IB
Friday, May 30, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, May 29, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

sebvi namely antibodies field research scientific technological others immunoglobulins designing design